Treatment of Pleural Effusion after Lobectomy and Lymphadenectomy for Primary Lung Cancer: A Case Report
The majority of malignant pleural effusion (MPE) is caused by metastatic disease: most commonly lung cancer in men and breast cancer in women. MPE worsens the quality of life in patients due to the occurrence of respiratory failure, compression of internal organs and violation of homeostasis. Existi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Medical Research and Development Corporation
2020-03-01
|
| Series: | International Journal of Biomedicine |
| Subjects: | |
| Online Access: | http://ijbm.org/articles/i37/ijbm_10(1)_cr1.pdf |
| Summary: | The majority of malignant pleural effusion (MPE) is caused by metastatic disease: most commonly lung cancer in men and breast cancer in women. MPE worsens the quality of life in patients due to the occurrence of respiratory failure, compression of internal organs and violation of homeostasis. Existing methods for MPE treatment have a number of disadvantages, including insufficient analgesia and the use of standard drainage tubes that do not adequately irrigate the pleural space with drugs, thereby reducing the drugs’ effectiveness. The proposed method for the treatment of MPE improves the treatment results by improving the drainage and introduction of drugs into the pleural cavity. |
|---|---|
| ISSN: | 2158-0510 2158-0529 |